share_log

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga ·  Apr 4 12:31

Gainers

  • Candel Therapeutics (NASDAQ:CADL) shares moved upwards by 64.3% to $2.76 during Thursday's regular session. The market value of their outstanding shares is at $80.9 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares increased by 61.38% to $2.1. The market value of their outstanding shares is at $5.0 million.
  • Eiger BioPharmaceuticals (NASDAQ:EIGR) shares moved upwards by 38.18% to $2.28. The company's market cap stands at $3.3 million.
  • Macrogenics (NASDAQ:MGNX) stock rose 32.55% to $18.12. The company's market cap stands at $1.1 billion.
  • Barinthus Biotherapeutics (NASDAQ:BRNS) shares increased by 29.55% to $3.77. The company's market cap stands at $146.7 million.
  • Curis (NASDAQ:CRIS) shares moved upwards by 24.62% to $16.7. The market value of their outstanding shares is at $98.4 million.

Losers

  • eFFECTOR Therapeutics (NASDAQ:EFTR) stock declined by 80.2% to $3.25 during Thursday's regular session. The company's market cap stands at $11.9 million.
  • Achilles Therapeutics (NASDAQ:ACHL) stock decreased by 24.17% to $0.91. The market value of their outstanding shares is at $37.1 million. As per the press release, Q4 earnings came out today.
  • Inotiv (NASDAQ:NOTV) shares fell 16.81% to $7.87. The company's market cap stands at $202.9 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) stock declined by 14.55% to $2.35. The company's market cap stands at $8.5 million.
  • Kintara Therapeutics (NASDAQ:KTRA) shares declined by 13.48% to $0.14. The market value of their outstanding shares is at $5.5 million.
  • Carmell (NASDAQ:CTCX) stock declined by 12.85% to $2.51. The market value of their outstanding shares is at $48.3 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment